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O B J E C T I V E S This study sought to determine the accuracy of Doppler echocardiography and
tissue Doppler imaging (TDI) measurements in detecting elevated left atrial pressure (LAP) in ambulant
subjects with chronic heart failure using directly measured LAP as the reference.
B A C KG ROUND Echocardiographic indexes including the ratio of transmitral to annular early diastolic
velocities (E/e=) may identify raised invasively measured left ventricular ﬁlling pressures when tested in cross-
sectional studies in some populations. The accuracy of these indexes when measured sequentially remains
untested.Wedetermined the accuracy of Doppler echocardiography and TDImeasurements in detecting elevated
directly measured LAP in ambulant subjects with stable chronic heart failure.
METHOD S Fifteen patients with New York Heart Association functional class II to III heart failure and
a permanently implanted direct LAP monitoring device underwent serial echocardiography. Simultane-
ous resting mean LAP, Doppler mitral inﬂow, mitral annular TDI, and pulmonary venous inﬂow velocities
were obtained on each occasion. Receiver-operator characteristic curve analysis was used to compare
the accuracy of the Doppler variables to detect an elevated device LAP 15 and 20 mm Hg.
R E S U L T S The patients (13 men, mean age: 71 years, mean left ventricular ejection fraction: 32 
12%) underwent 60 simultaneous echocardiographic studies and LAP measurements with a median of
4 (1 to 7) studies per patient. Mean LAP was 16.9 (range 5 to 39 mm Hg) at echocardiography (n  60).
E/e= had the greatest accuracy for detection of LAP 15 mm Hg with an area beneath the
receiver-operator characteristic curve0.9. In comparison, area under the curve for mitral E velocity and
mitral E/A were 0.77 and 0.76, respectively (p  0.008 vs. E/e= medial and average).
CONC L U S I O N S Single and serial measurements of mitral inﬂow and mitral annular TDI velocities
(E/e=) can reliably detect raised directly measured LAP in ambulant subjects with compensated chronic heart
failure. (Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients [HOMEOSTASIS];
NCT00547729) (J AmColl Cardiol Img 2011;4:927–34) © 2011 by the American College of Cardiology Foundation
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928ndexes such as the ratio of transmitral to annular
early diastolic velocities (E/e=) have been success-
fully used to identify raised left ventricular (LV)
filling pressure in hospitalized subjects (1–3).
However, a recent study has questioned the utility
of E/e= in patients with acutely decompensated
advanced heart failure, particularly in patients with
cardiac resynchronization therapy and/or extensive
LV remodeling (4). Moreover, testing of E/e= and
other echocardiographic indexes has generally been
See page 935
performed at a single time-point and has compared
these indexes to a range of invasively measured
indexes of LV filling pressure. To date, no studies
have tested the accuracy of repeated measurements
of echo estimates of LV filling pressure and none
have compared directly measured left atrial pressure
(LAP) (5), which is an important determinant of
pulmonary capillary pressure and therefore
of pulmonary edema and symptoms (6).
We sought to determine the accuracy of
echo indexes for the detection of elevated
LAP at single and serial time-points in
patients with advanced chronic heart fail-
ure and an implanted sensor that accu-
rately measures direct LAP.
M E T H O D S
Patients. Fifteen patients with New York
Heart Association (NYHA) functional class
II to III heart failure regardless of LV
jection fraction enrolled in the HOMEOSTASIS
Hemodynamically Guided Home Self-Therapy in
evere Heart Failure Patients) trial underwent serial
chocardiography at 2 centers. The 15 subjects
nrolled in this substudy were recruited from the 2
enters in New Zealand that were participating in
he HOMEOSTASIS trial. This trial is a human
easibility study to evaluate the safety and function-
lity of a permanently implantable LAP monitoring
ystem (HeartPOD, St. Jude Medical Inc., Minne-
Zealand; §Cardiology Division of the Department of Medicine, Ceda
CRMD Technology Incubation, St. Jude Medical, Minneapolis, Minn
State University, Columbus, Ohio; and the #Department of Cardiology,
The HOMEOSTASIS trial (HeartPOD LAP monitoring device) was s
supported by a grant from the National Heart Foundation of New Zealan
in the manufacturer of the study device. Drs. Abraham and Troughton ha
Medical. All other authors have reported that they have no relationships
ities
y
gManuscript received December 19, 2010; revised manuscript received July 12polis, Minnesota) (7). Inclusion criteria were
YHA functional class II to IV heart failure 6
onths regardless of LV ejection fraction. Subjects
ad to have at least 1 exacerbation of heart failure
equiring parenteral therapy during the preceding
ear.
Exclusion criteria included atrial fibrillation, ste-
otic valve lesions, hypertrophic cardiomyopathy,
oderate or severe semilunar valvular regurgitation,
alvular prosthesis, and the presence of a pericardial
ffusion. Patients with atrial fibrillation were ini-
ially excluded from the HOMEOSTASIS study
ue to the increased potential of thromboembolic
omplications with the direct LAP sensor. A New
ealand multicenter research ethics committee ap-
roved the study. All patients gave written in-
ormed consent.
Echocardiography. Serial echocardiography was un-
ertaken after implantation of the LAP monitoring
evice and at 2, 4, 6, and 12 weeks and every 3
onths thereafter during 1 year of follow-up. Usual
eart failure medications were taken by all subjects
n the day of echocardiography. Images were ac-
uired with the patient in the left lateral decubitus
osition during quiet respiration. Acquisition of
-dimensional images and Doppler indexes were
ndertaken according to American Society of
chocardiography guidelines (8–10). Sonographers
ere blinded to the current LAP measurement.
he lowest filter settings were used to ensure that a
omplete Doppler spectrum was obtained in each
nstance. A sweep speed of 50 to 100 mm/s was
sed. Care was taken to minimize the angle be-
ween the Doppler signal and the plane of longitu-
inal excursion of the LV.
The data acquired was stored electronically and
ater analyzed offline using CardioVascular (Pro-
olv, Indianapolis, Indiana) and EchoPAC (GE
ealthcare, Chalfont St. Giles, UK) software by a
ingle investigator (J.R.) who was blinded to LAP.
ean values of each parameter were determined by
easuring 3 consecutive cardiac cycles (excluding
remature beats and the subsequent cardiac cycle).
inai Medical Center, Los Angeles, California;
a; ¶Division of Cardiovascular Medicine, Ohio
cess Alexandra Hospital, Queensland, Australia.
ored by St. Jude Medical Inc. Dr. Ritzema was
rs. Eigler and Whiting have a financial interest
ceived honoraria or consulting fees from St. Jude
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E/e= ratio of transmitral to
annular early diastolic veloc
LAP left atrial pressure
LV left ventricle
MRmitral regurgitation
NYHA New York Heart
Association
PCWP pulmonary capillar
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929Doppler measurements. Standard Doppler mitral
nflow measurements were acquired on each occa-
ion. Tissue Doppler imaging (TDI) included the
arly (e=) and late diastolic (a=) velocities from
edial and lateral mitral annular margins (9). The
atio of early transmitral mitral to early myocardial
elaxation velocity (E/e=) was calculated for both the
edial (E/e=medial) and lateral (E/e=lateral) mitral
nnular sites and the average (E/e=average) from
oth annular sites (11). TDI data were excluded
rom analyses in 1 subject found to have pericardial
onstriction with normal myocardial function. The
ntraobserver variability for echocardiographic mea-
urements was determined by repeating the mea-
urement of 10 variables in 9 subjects.
Left atrial pressure recordings. Mean LAP was ob-
ained from high-fidelity LAP waveforms of 15-s
uration that were acquired immediately prior to
oppler echocardiography of mitral inflow. TDI
ndexes were acquired thereafter. Previous analyses
n this cohort have shown that device LAP corre-
ates very strongly with pulmonary capillary wedge
ressure (PCWP) at follow-up right heart catheter-
zation (r 0.98) at 3 and 12 months. Mean sensor
rift was 1.3 mm Hg and the average difference
etween device LAP and PCWP  1.3  3.8 mm
g at 1 year (7).
Statistics. Statistical analyses were performed using
PSS software (version13, SPSS Inc., Chicago,
llinois). The dependency among the repeated mea-
urements within individuals was appropriately ac-
ounted for using repeated measures analyses.
ixed model analysis of variance was used to test
Table 1. Baseline Demographics and Laboratory Values at the
Time of Initial Echocardiographic Study
Range
Sex, men/women 13/2
Age, yrs, median 70 60–83
BSA, m2 2.0 0.2 1.6–2.3
Etiology: ischemic/idiopathic/HTN 12/2/1
NYHA functional class II/III 8 (53)/7 (47) II–III
6-min walk test, m 363 83 205–490
Creatinine, mg/dl 1.5 0.4 0.9–2.4
CRT 7 (47)
Heart rate, min–1 65.4 11 50–89
Systolic BP, mm Hg 110.7 23 72–150
Diastolic BP, mm Hg 64.3 13.2 44–90
LAP, mm Hg 17.3 8 7–28.7
Values are n, mean  SD, or n (%) and range; n  15.
BP  blood pressure; BSA  body surface area; CRT  cardiac resynchro-
nization therapy device; HTN  hypertension; LAP  left atrial pressure;
NYHA  New York Heart Association.he association between LAP and echo indexeswithin individuals across all echocardiographic
studies. Receiver-operator characteristic curve anal-
ysis was used to compare the sensitivity and speci-
ficity of the Doppler variables to detect LAP 15
and20 mm Hg. All data are presented as mean
SD, unless otherwise stated. Statistical significance
was defined as p  0.05 (2-tailed).
R E S U L T S
Baseline characteristics. Fifteen subjects with
YHA functional class II to III heart failure were
ecruited (Table 1). Twelve had ischemic heart
isease. Seven subjects had a cardiac resynchroni-
ation device for the duration of the study. Most
ubjects had significant LV dilation and systolic
ysfunction (Table 2), although 2 subjects had an
V ejection fraction 40%. A spectrum of overall
iastolic filling patterns ranging was seen (Table 2).
Serial LAP measurement and echocardiographic stud-
ies. Sixty simultaneous echocardiographic studies
nd LAP measurements were obtained with a




LVEDV, ml 243.9 111 100
LVEDVI, ml/m2 123.5 56 100
LVESVI, ml/m2 89.9 55 100
LVEF, % 31.6 12 100
LVSV, ml 66.3 18 100
E velocity, cm/s 75.8 24 93.3
A velocity, cm/s 68.2 24 93.3
A duration, ms 172.1 32.8 66.7
E/A 1.3 0.9 86.7
DT, ms 214.5 67 86.7
S, cm/s 36.6 17 73.3
D, cm/s 51.5 27 80
PVAR velocity, cm/s 24.7 9 46.7
PVAR duration, ms 202.3 36 33
e=medial, cm/s 3.8 1.2 93.3
e=lateral, cm/s 5.2 2 93.3
a=medial, cm/s 5.3 2.3 100
a=lateral, cm/s 5.3 2.6 100
E/e=medial 21 10.4 93.3
E/e=lateral 16.6 9.3 93.3
LAmax, ml 105.6 26 66.7
LAmaxI, ml/m2 54.9 13 66.7
n  15. All Doppler measurements are single plane (apical 4-chamber) unless
noted. Volumetric data are biplane measurements. Data included from 2
subjects with left ventricular ejection fraction 40%.
E/e=average  ratio of the early mitral inﬂow velocity and mean of the
medial and lateral annular tissue Doppler velocities; I  indexed to body
surface area; LAmax  maximal left atrial volume; LVEDV  left ventricular
end-diastolic volume; LVEF  left ventricular ejection fraction; LVESV  left
ventricular end-systolic volume; LVSV  left ventricular stroke volume; PVAR 
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930median of 4 (1 to 7) studies per patient over a
median follow-up period of 23 (range 0 to 52)
weeks. One patient had a single echo study. Vari-
ation from follow-up occurred due to patient death
(5 studies), intercurrent illness (9 studies), recurrent
arrhythmias (7 studies), and technical reasons in-
cluding LAP sensor malfunction (39 studies).
There was wide variation in LAP at the time of
echocardiography (range 5 to 39 mm Hg). An LAP
15 or 20 mm Hg was seen in 51.7% and 35% of
studies, respectively. All subjects exhibited variation
in LAP across visits and the coefficients of variation
in individuals’ LAP at the time of echocardiography
ranged from 16.7% to 61.3% across all echo studies.
The highest LAPs (25 mm Hg) were associated
with diastolic mitral regurgitation (MR). The co-
efficients of variation for the intraobserver variabil-
ity of echocardiographic measurements were 4.0%,
5.5%, and 6.7% for E, DT, and e=, respectively.
Tissue Doppler and transmitral indexes were reli-
ably obtained in the majority (80%) of studies.
Complete mitral inflow measurements were occa-
sionally not possible due to fusion of E and A
waves. High-quality Doppler spectra of pulmonary
venous flow were acquired in 71.7% of studies. In
26 (43.3%) echocardiographic studies, subjects had
Figure 1. Intrapatient Correlation of E/e= With Simultaneous LA
Results are shown for baseline left atrial pressure (LAP) versus base
E/e= average (C), and E/e= lateral (D). In B to D, r is the pooled intra
line reﬂects the pooled intrapatient association also derived from t
cardiac resynchronization device, red indicates data from subjects w
enrolled, tissue Doppler imaging data were excluded from analyses
ratio of the early mitral inﬂow velocity and mean of the medial and latmoderate or greater MR and in 12 (20%) there was
severe MR.
Correlation of echo indexes with LAP across serial
studies. There were significant correlations between
erial LAP measurements and E/e=medial (r 
.46, p  0.005) (Fig. 1) within individuals across
erial echocardiographic studies. Correlations be-
ween serial LAP and E/e=average or E/e=lateral
Fig. 1), mitral inflow, or pulmonary vein parame-
ers did not achieve statistical significance when
orrected for multiple measurements within
ndividuals.
The relationship between LAP and E/e=medial
as unchanged when analyzed as change from
aseline or percent change from baseline (r  0.46;
 0.005, for both comparisons).
Detection of elevated LAP. Doppler variables accu-
ately detected LAP 20 and 15 mm Hg
Table 3). Areas under respective receiver-operator
haracteristic curves for the detection of LAP 15
ere 0.95 (E/e=average), 0.94 (E/e=medial), and
.90 (E/e=lateral). An E/e=average of14, E/e=me-
ial of 15, and E/e=lateral 12 had sensitivity of
4%, 84%, and 73% and specificity of 96%, 91%,
nd 87%, respectively, for the detection of LAP
15 mm Hg. The E/e= ratio was consistently the
E/e= medial (A), and serial data for LAP versus E/e= medial (B),
ient correlation coefﬁcient from mixed model analysis. The ﬁtted
ixed model analysis. Green indicates data from subjects with a
a left ventricular ejection fraction 40%. n  14 (15 subjects
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931best Doppler parameter for predicting LAP 20
and 15 mm Hg across all echocardiographic
tudies regardless of which annular site was used.
erial E/e=average and medial measurements were
etter able than E and E/A to detect an LAP 15
mm Hg (Fig. 2). Consideration of other echo
indexes in addition to E/e= did not improve the
accuracy for the detection of an elevated LAP. The
ability to identify low LAP was limited in this study
Table 3. Sensitivity, Speciﬁcity, and Accuracy of Serial Doppler
Variable p Value AUC Cutpoint (>)
Detecting LAP 15
E/e=average 0.0001 0.95 14
E/e=medial 0.0001 0.94 15
E/e=lateral 0.0001 0.90 12
E velocity 0.001 0.77 60
E/A 0.001 0.76 0.85
PVARdur-Adur 0.017 0.83 14
Detecting LAP 20
E/e=average 0.0001 0.87 15
E/e=medial 0.0001 0.85 15
E/e=lateral 0.0001 0.85 15
E velocity 0.019 0.69 61
E/A NS 0.6 0.74
PVARdur-Adur NS 0.82 19
Detecting LAP 12
E/e=average 0.001 0.80 14
E/e=medial 0.001 0.78 15
E/e=lateral 0.001 0.8 11
E/A 0.005 0.74 85
E velocity 0.015 0.71 60
PVARdur-Adur NS 0.72 12
Adur  A-wave duration; AUC  area under the curve; NPV  negative predicti
of pulmonary venous atrial reversal; other abbreviations as in Tables 1 and 2.
Figure 2. ROC Curves for the Prediction of LAP >15 mm Hg Us
Results are shown for prediction of LAP 15 mm Hg using E/e= at
venous velocities (B). n  15 but tissue Doppler imaging data were
constriction. AUC  area under the curve; ROC  receiver-operator curby relatively few LAP 8 mm Hg (n  6);
however, 33% of LAP were12 mm Hg. The E/e=
ratio still provided modest accuracy in detecting
LAP 12 mm Hg (Table 3).
When only a single time-point for each indi-
vidual (the first echo study) was included in the
analysis, E/e=medial demonstrated greater accu-
racy for detecting LAP 20 (area under the
curve: 0.88, sensitivity: 100%, specificity: 75%)
surements for the Estimation of LAP
Sensitivity Speciﬁcity PPV NPV Accuracy
84 96 95 85 90
84 91 91 84 88
73 87 86 74 80
71 71 72 70 71
70 83 83 69 76
80 82 57 93 82
82 81 70 89 81
88 74 65 92 79
72 81 68 68 78
71 62 54 78 65
68 53 45 75 58
75 84 50 89 83
94 68 62 95 77
88 68 60 91 75
70 75 60 83 73
94 64 55 96 74
71 63 46 83 65
83 64 71 78 74
lue; NS  not signiﬁcant; PPV  positive predictive value; PVARdur  duration
Echo Doppler Indexes
different annular sites (A) and by mitral inﬂow and pulmonary
luded from analyses in one subject found to have pericardialMea
ve vaing
the
excve; other abbreviations as in Figure 1.
tions as in
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932and 15 mm Hg (area under the curve: 1,
sensitivity: 100%, specificity: 100%).
As shown in Figure 3, although an optimal single
cutpoint for E/e=medial of 15 accurately identi-
fied an LAP 15, an E/e=medial 12 essentially
“ruled out” an elevated LAP with a sensitivity of
96% and a negative predictive value of 90%,
whereas an E/e= 18 “ruled in” an elevated LAP
Mean LAP Versus Categorical E/e= Medial Ratio (<15 and >15)
dies (n  48)
subjects enrolled, tissue Doppler imaging data were excluded
ses in 1 subject found to have pericardial constriction). Abbrevia-
Figure 1.
Figure 4. Concordant Temporal Changes in Left Atrial Pressure
Echocardiogram Studies
n  12, one subject was excluded as he had pericardial constriction
than one E/e= measurement.(specificity: 96%, positive predictive value: 95%).
Intermediate values of E/e= (8 to 14) have reduced
discriminatory power.
D I S C U S S I O N
Although the accuracy of Doppler indexes in-
cluding E/e= in identifying invasively measured
elevated LV filling pressures has been demon-
strated in multiple catheter laboratory-based
cross-sectional studies, their accuracy during se-
quential testing in ambulant subjects had not
been established. The availability of an implant-
able sensor that accurately measures direct LAP
provided a unique opportunity to validate the
accuracy of Doppler estimates of filling pressure
in ambulant subjects. This is the first time that
directly measured LAP has been used as the
“gold-standard” reference in investigations of this
kind. We found single and serial measurements
of E/e=medial correlated significantly with simul-
taneous LAP. When serial testing was under-
taken in these subjects, an E/e= 15 accurately
detected an LAP elevated into the decompen-
sated range, with an E/e= 18 essentially “ruling
in” an elevated LAP and an E/e= 12 essentially
excluding an elevated LAP. These results indi-
cate that physicians can be confident that E/e=
Hg) and E/e= Medial Ratio in 12 Subjects With 2 or More
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933can be used to accurately identify elevated (15
mm Hg) filling pressures during outpatient
follow-up of ambulant patients with advanced
chronic heart failure.
Serial LAP and echocardiographic measurements.
There are conflicting data regarding the utility of
echo indexes of LV filling pressure to track short-
term (hours) changes in PCWP (4,12,13) in sub-
jects in the intensive care unit. This is the first study
to determine the relationship between serial simul-
taneously measured LAP and Doppler indexes of
diastolic function in ambulant subjects with ad-
vanced heart failure. When we tested the associa-
tion between repeated concurrent echocardio-
graphic and LAP measurements in our cohort,
there was a significant association between LAP
and E/e=medial, indicating that these indexes track
each other over time (Fig. 4). This finding was
consistent within individuals and across the group,
despite these subjects having LV volumes and
cardiac resynchronization therapy comparable to
those enrolled in a recent study of subjects with
acutely decompensated heart failure, in which
Doppler estimates of PCWP were less accurate (4).
There was a slightly more modest correlation
between LAP and E/e= in our study when com-
pared with previous studies when E/e= was com-
pared with a single invasive measurement of LV
filling pressure, which is likely to reflect several
factors including smaller sample size, less heter-
ogeneity in patients, and appropriate statistical
adjustment for multiple measurements from in-
dividuals in the current study. The association
between E/e= and LAP was less robust at higher
LAP (20 mm Hg). A linear increase in E
velocity did not occur when LAPs were very high
(30 mm Hg); this could reflect an increased LV
early diastolic pressure reflecting severe relaxation
abnormalities and lower transmitral gradients in
early diastole in severe heart failure. In chronic
heart failure, there is a monophasic decline in the
e= velocity with increasing relaxation abnormality
and diastolic dysfunction, but once this velocity
approximated 2 cm/s, these velocities did not
change despite further variation in LAP. Some of
the scatter at higher pressures may reflect MR as
all significantly elevated LAPs (25 mm Hg)
were associated with at least moderate functional
MR and the accuracy of E/e= measurements in
this setting is uncertain, particularly when LV
systolic function is preserved (14). However, in
this heterogeneous population with advanced
predominantly systolic heart failure and at leastmild-moderate secondary MR, E/e= reliably de-
tected an elevated LAP.
The TDI indexes were highly reproducible in
this study and were obtained in most subjects.
Measurement variability was consistent with other
reports.
There were no significant associations among
repeated single Doppler mitral inflow, pulmonary
venous flow measurements, and LAP, which may
reflect greater difficulty in acquisition of these in-
dexes and the impact of other diastolic processes
such as left atrial function and myocardial relaxation
(15,16).
Study limitations. This study included mainly
lder adults with severe heart failure; therefore,
pplicability to a wider heart failure population
ncluding younger patients or less severe heart
ailure is less certain. Subjects with atrial fibril-
ation were not enrolled, but findings from pre-
ious studies suggest these data are likely to be
pplicable. Although the number of subjects in-
luded in the study was small, and incomplete
ollow-up could potentially have introduced bias,
he total number of echocardiographic studies
nalyzed was comparable to existing reports
1,12). However, these findings require validation
n a larger cohort of patients. To reduce the
ependency of repeated measures occurring within
ndividuals, mixed-model analysis of variance was
sed for any correlations. The variable multiple
bservations per subject may have biased the
eceiver-operator characteristic curve analyses
nd decision statistics because the data do not
onstitute independent observations.
C O N C L U S I O N S
Measurement of E/e= reliably detected normal or
raised directly measured LAP in ambulant subjects
with advanced chronic heart failure. These findings
provide validation of the accuracy of serial Doppler
estimates of LV filling pressure and support the
serial use of this noninvasive index to assess filling
pressures.
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